Cyberzenhub.com – A federal court judge has directed the Trump administration to clarify how the Department of Defense’s recently implemented testosterone screening initiative and hormone replacement therapy program might influence the government’s rationale for excluding transgender individuals from military service. Judge Ana Reyes is examining whether the Pentagon’s approach to hormone treatment creates an inconsistency in how transgender servicemembers are compared to their cisgender counterparts. In a directive issued this week, Judge Reyes requested that attorneys representing both sides in the ongoing litigation concerning the transgender military exclusion supply supplementary details regarding the screening procedures and therapeutic guidelines. This judicial inquiry builds upon her previous oversight of the case challenging the administration’s policy toward transgender personnel.

Throughout the legal proceedings, the Pentagon has maintained that the financial burden and operational consequences associated with gender-affirming hormone therapy negatively affect the combat effectiveness of transgender soldiers. The department’s position suggests that providing…